| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/22/2004 | WO2004006848A2 Combination therapies with ftc for the treatment of hepatitis b virus infection |
| 01/22/2004 | WO2004006847A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 01/22/2004 | WO2004006843A2 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
| 01/22/2004 | WO2004006842A2 Combinations of drugs for the treatment of neoplasms |
| 01/22/2004 | WO2004006833A2 Bowel cleansing composition |
| 01/22/2004 | WO2004006832A2 Methods and compounds for reducing biofilm formation |
| 01/22/2004 | WO2003097665A3 Mid 241 receptor, a novel g-protein coupled receptor |
| 01/22/2004 | WO2003092542A3 Injectable chondrocyte implant |
| 01/22/2004 | WO2003090778A3 Dna vaccine combined with an inducer of tumor cell apoptosis |
| 01/22/2004 | WO2003080545A3 Substituted phenylacetic acids |
| 01/22/2004 | WO2003076603A3 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions |
| 01/22/2004 | WO2003075946A3 Treatment of type i diabetes mellitus using growth hormone antagonist |
| 01/22/2004 | WO2003072802A3 Carboxyfullerenes and methods of use thereof |
| 01/22/2004 | WO2003068161A3 Composition and method for protecting labile active components |
| 01/22/2004 | WO2003066087A3 Kinases involved in the regulation of energy homeostasis |
| 01/22/2004 | WO2003064383A3 Phosphorus-containing compounds & uses thereof |
| 01/22/2004 | WO2003063789A3 L-carnitine for treatment of hearing loss |
| 01/22/2004 | WO2003061402A3 Reduction of renal damage in companion animals |
| 01/22/2004 | WO2003060521A3 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 01/22/2004 | WO2003055447A3 Heterocyclic acridone inhibitors of impdh enzyme |
| 01/22/2004 | WO2003049690A3 Hiv integrase inhibitors |
| 01/22/2004 | WO2003045431A3 Methods for treating cancer using a combination of a tumor-derived dendritic cell inhibitory factor antagonist and a toll-like receptor agonist |
| 01/22/2004 | WO2003037257A3 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
| 01/22/2004 | WO2003026570A3 Reduced toxicity cisplatin formulations and methods for using the same |
| 01/22/2004 | WO2003025121A3 Igf-binding protein-derived peptide or small molecule |
| 01/22/2004 | WO2003020962A3 Method of identifying glycosyl transferase binding compounds |
| 01/22/2004 | WO2002092573A3 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 01/22/2004 | WO2002078643A3 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 01/22/2004 | WO2002076439A3 Compounds capable of modulating the activity of multidrug transporters and therapeutic use of the same |
| 01/22/2004 | WO2002072093A3 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 01/22/2004 | US20040014818 Bactericidal preparation |
| 01/22/2004 | US20040014795 Calcium channel blockers; cardiovascular disorders; synergistic mixtures |
| 01/22/2004 | US20040014789 Novel glucagon antagonists/inverse agonists |
| 01/22/2004 | US20040014788 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht receptor agonists |
| 01/22/2004 | US20040014782 Combination therapy for the treatment of diseases involving inflammatory components |
| 01/22/2004 | US20040014779 Testing for immunology response moderators; viricides, antitumor agents |
| 01/22/2004 | US20040014778 Heteroaryl - fused nitrogen heterocycles as therapeutic agents |
| 01/22/2004 | US20040014771 Synergistic mixture of antiserotonin agents and serotonin reuptake inhibitors; analgesics; irritable bowel syndrome |
| 01/22/2004 | US20040014761 Treatment of female sexual dysfunction with phosphodiesterase inhibitors |
| 01/22/2004 | US20040014757 Method for the treatment or prevention of viral infection using nucleoside analogues |
| 01/22/2004 | US20040014751 Antidiabetic agents |
| 01/22/2004 | US20040014750 Therapy, prevention atherosclerosis; cardiovascular disorders; anticholesterol agents; bactericides; prevention infections |
| 01/22/2004 | US20040014749 Sulfhydryl rifamycins and uses thereof |
| 01/22/2004 | US20040014741 Dietetics; antidiabetic agents; antiinflammatory agents |
| 01/22/2004 | US20040014739 Low dosage; anxiolytic agents, psychological disorders, cognition activators |
| 01/22/2004 | US20040014729 Bone disorders; anticancer agents |
| 01/22/2004 | US20040014727 Stimulant bone proliferation |
| 01/22/2004 | US20040014726 Method for the preparation of a pharmaceutical composition, and its use |
| 01/22/2004 | US20040014723 Calcilytic compounds |
| 01/22/2004 | US20040014715 Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 01/22/2004 | US20040014706 Using protein antagonist; therapy for congestive heart failure; blocking gene expression |
| 01/22/2004 | US20040014700 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents |
| 01/22/2004 | US20040014693 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals |
| 01/22/2004 | US20040014689 Endoparaciticidal and ectoparasiticidal agents |
| 01/22/2004 | US20040014686 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 01/22/2004 | US20040014682 Solvent extraction using alcohol; immunosuppressants; autoimmune diseases; rheumatic diseases |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040014656 Method for diagnosing neuronal deseases and for treating primary hemostasis deficiency |
| 01/22/2004 | US20040014654 Cardiovascular disorders; anticholesterol agents; administering apolipoproteins and phospholipids mixture |
| 01/22/2004 | US20040014636 Pharmaceutical compositions comprising a modulator of adamts-1 |
| 01/22/2004 | US20040014635 Anticancer agents |
| 01/22/2004 | US20040014219 Comprises expression vector coding fusion protein associated cell proliferation and/or differentiation; gene therapy; animal model for disease |
| 01/22/2004 | US20040014208 Methods for culturing human lung mast cells and uses thereof |
| 01/22/2004 | US20040014190 Stable plasminogen activator inhibitor for treatment of thrombosis and cardiovascular diseases |
| 01/22/2004 | US20040014187 Comprises genetically engineered protease for treatment tumors; gene therapy |
| 01/22/2004 | US20040014171 Soluble CTLA4 mutant molecules and uses thereof |
| 01/22/2004 | US20040014162 Regulating levels of tyrosine phosphatase activity of protein tyrosine phosphatase zeta/receptor-like protein (RPTP beta/zeta) in cells and/or tissues; antitumor agents; angiogensis inhibitors |
| 01/22/2004 | US20040014111 Methods for the identification of IKKalpha function and other genes useful for treatment of imflammatory diseases |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040013745 Process of making a supplement for digestive ailment |
| 01/22/2004 | US20040013744 Antibiotic ointment for treating skin rash; simple and inexpensive |
| 01/22/2004 | US20040013741 Gastrointestinal compositions |
| 01/22/2004 | US20040013739 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 01/22/2004 | US20040013730 Insertion into vagina; prevention, therapy for infections |
| 01/22/2004 | US20040013729 Mydriatic agent in viscoelasticity polymer |
| 01/22/2004 | US20040013728 Controlled drug delivery system using the conjugation of drug to biodegradable polyester |
| 01/22/2004 | US20040013720 Receptor antagonist-lipid conjugates and delivery vehicles containing same |
| 01/22/2004 | US20040013718 Three-dimensional body; antiinflammatory agents, autoimmune diseases; in situ response; side effect reduction |
| 01/22/2004 | US20040013716 Sustained release of drug antagonist; analgesic reservoir, barrier layer |
| 01/22/2004 | US20040013706 Stress and radiation resistance; antiallergens; antiinflammatory agents |
| 01/22/2004 | US20040013668 Polypeptide antibody which binds to low density lipoprotein; quantitative analysis |
| 01/22/2004 | US20040013660 Synergistic mixtures |
| 01/22/2004 | US20040013643 Mixture of immunomoderators and antiinflammatory agents |
| 01/22/2004 | US20040013635 Stimulating filaggrin synthesis with legum seed extracts |
| 01/22/2004 | US20040013623 Chemiluminescent treatment of acne |
| 01/22/2004 | DE10327874A1 Injektionsanästesiemittel in Kombination mit Xenon Injektionsanästesiemittel in combination with xenon |
| 01/22/2004 | DE10230769A1 Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren New pharmaceutical compositions based on new anticholinergics and PDE IV inhibitors |
| 01/22/2004 | DE10230752A1 Neue Arzneimittelkompositionen auf der Basis von Magnesiumsalzen und Fibrinolytika New pharmaceutical compositions based on magnesium salts and fibrinolytics |
| 01/22/2004 | DE10230751A1 Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern New pharmaceutical compositions based on new anticholinergics and EGFR kinase inhibitors |
| 01/22/2004 | DE10230750A1 Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten New pharmaceutical compositions based on new Anticholonergika and NK1 receptor antagonists |
| 01/22/2004 | DE10230381A1 Verwendung von Inhibitoren der Alanyl-Aminopeptidasen und diese umfassende pharmazeutischen Zubereitungen Use of inhibitors of alanyl-aminopeptidase, and pharmaceutical preparations comprising them |
| 01/22/2004 | DE10230027A1 Neue Arzneimittelkombinationen auf der Basis von Natriumkanalblockern und Magnesiumsalzen New drug combinations on the basis of sodium channel blockers and magnesium salts |
| 01/22/2004 | DE10228326A1 Verwendung von Macrolid- und/oder Tetracyclin-Verbindungen und/oder Gyrasehemmer enthaltenden Präparationen zur Prophylaxe und therapeutischen Behandlung von Migräne und Migräne-verwandten Erkrankungen Use of macrolide and / or tetracycline compounds and / or gyrase inhibitor-containing preparations for the prophylaxis and therapeutic treatment of migraine and migraine related disorders |
| 01/22/2004 | CA2782498A1 Tablet composition containing kampo medicinal extract and its manufacturing process |
| 01/22/2004 | CA2743341A1 Drugs for treating or preventing brain injury and a method of screening the same |
| 01/22/2004 | CA2493871A1 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 01/22/2004 | CA2493675A1 Genes |
| 01/22/2004 | CA2493373A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | CA2493111A1 Diagnosis and prevention of cancer cell invasion |
| 01/22/2004 | CA2492772A1 Activated checkpoint therapy and methods of use thereof |